Moreover, the IC50 value was negatively correlated with VEGFR‐2 expression in different HCC cells, indicating that the efficacy of apatinib does differ widely between individual cell lines that expressed different levels of VEGFR‐2. The gene discussed is KDR; the disease is hepatocellular carcinoma.